TrialDiabetologia2008

Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles.

K Swaminathan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.